HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations
HR2882 Further Consolidated Appropriations Act of FY2024
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations; HR 5894/S 2624 FY24 Labor HHS Education Act, National HHT Center of Excellence Program
HR2882 Further Consolidated Appropriations Act of FY2024
Duration: September 1, 2010
to
December 31, 2011
General Issues: Defense , Health Issues , Medical/Disease Research/Clinical Labs , Budget/Appropriations
Spending: about $485,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2010: U.S. Senate, House of Representatives, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Defense - Dept of (DOD)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 18.
Original Filing: 301553234.xml
Lobbying Issues
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations
HR2882 Further Consolidated Appropriations Act of FY2024
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations; HR 5894/S 2624 FY24 Labor HHS Education Act, National HHT Center of Excellence Program
HR2882 Further Consolidated Appropriations Act of FY2024
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 26.
Original Filing: 301542062.xml
Lobbying Issues
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations; HR 5894/S 2624 FY24 Labor HHS Education Act, National HHT Center of Excellence Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 19, 2023.
Original Filing: 301508139.xml
Lobbying Issues
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4365/S 2587 FY24 Defense Appropriations Act, DoD research on vascular malformations; HR 5894/S 2624 FY24 Labor HHS Education Act, National HHT Center of Excellence Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 19, 2023.
Original Filing: 301482569.xml
Lobbying Issues
HR 4365/ S-- FY24 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4365/S-- FY24 Defense Appropriations Act, DoD research on vascular malformations; FY24 Labor HHS Education Act, National HHT Center of Excellence Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 17, 2023.
Original Filing: 301453021.xml
Lobbying Issues
FY24 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY24 Defense Appropriations Act, DoD research on vascular malformations; FY24 Labor HHS Education Act, National HHT Center of Excellence Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 17, 2023.
Original Filing: 301429437.xml
Lobbying Issues
Research Opportunities at the Department of Defense
DoD research on vascular malformations
HR 8236/S. no bill #, FY23 Defense Appropriations Act
HR 2617/PL 117-328, Consolidated Appropriations Act, fiscal year 2023, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
National HHT Centers of Excellence grant program
HR 8294/S no bill #, FY22 Labor HHS Education Act
HR 2617/PL 117-328, Consolidated Appropriations Act, fiscal year 2023,
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413563.xml
Lobbying Issues
Research Opportunities at the Department of Defense
DoD research on vascular malformations
HR 8236/S. no bill #, FY23 Defense Appropriations Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
National HHT Centers of Excellence grant program
HR 8294/S no bill #, FY22 Labor HHS Education Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 18, 2022.
Original Filing: 301383589.xml
Lobbying Issues
Research Opportunities at the Department of Defense
DoD research on vascular malformations
HR 8236, FY23 Defense Appropriations Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
National HHT Centers of Excellence grant program
HR 8294, FY22 Labor HHS Education Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 20, 2022.
Original Filing: 301368718.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 2471, Consolidated Appropriations Act for fiscal year 2022
DoD research on vascular malformations
FY23 Defense Appropriations Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
HR 2471, Consolidated Appropriations Act for fiscal year 2022
National HHT Centers of Excellence grant program
FY22 Labor HHS Education Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 20, 2022.
Original Filing: 301336677.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 4432/S 3023 FY22 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
FY22 Labor-HHS-Education Act, funding for a national HHT diagnosis and treatment initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305866.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 4432, FY22 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
FY22 Labor-HHS-Education Act, funding for a national HHT diagnosis and treatment initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 19, 2021.
Original Filing: 301282363.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 4432, FY22 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
FY22 Labor-HHS-Education Act, funding for a national HHT diagnosis and treatment initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 16, 2021.
Original Filing: 301254557.xml
Lobbying Issues
Research Opportunities at the Department of Defense
FY22 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
FY22 Labor-HHS-Education Act, funding for a national HHT diagnosis and treatment initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 13, 2021.
Original Filing: 301230698.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 7617/S No bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
HR 133, PL 116-260, FY 21 Omnibus and COVID Relief and Response Act, research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
HR 7614, S no bill number, FY21 Labor-HHS-Education act, NIH and CDC research on HHT
HR 133, PL 116-260, FY 21 Omnibus and COVID Relief an Response Act, NIH and CDC research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research Opportunities at the Department of Defense, the National Institutes of Health, and the Centers for Disease Control and Prevention
HR 7617/S no bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
HR 7614/ S no bill number, FY21 Labor-HHS-Education Act, NIH and CDC research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216183.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 7617/S No bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations
NIH research on HHT
HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research Opportunities at the Department of Defense, the National Institutes of Health, and the Centers for Disease Control and Prevention
HR 7617/S no bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
HR 7614/ S no bill number, FY21 Labor-HHS-Education Act, NIH and CDC research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 17, 2020.
Original Filing: 301191154.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 7617/S No bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474, Department of Defense Appropriations Act 2020, research on vascular malformations
HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations
HR 7614/S. no bill number, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020, NIH research on HHT
HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Lobbying Issues
Research Opportunities at the Department of Defense, the National Institutes of Health, and the Centers for Disease Control and Prevention
HR 7617/S no bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
HR 7614/ S no bill number, FY21 Labor-HHS-Education Act, NIH and CDC research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 17, 2020.
Original Filing: 301191161.xml
Lobbying Issues
Research Opportunities at the Department of Defense
HR 7617/S No bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
Research on vascular malformations
HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations
NIH research on HHT
HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Lobbying Issues
Research Opportunities at the Department of Defense, the National Institutes of Health, and the Centers for Disease Control and Prevention
HR 7617/S no bill number, FY21 Defense Appropriations Act, DoD research on vascular malformations
HR 7614/ S no bill number, FY21 Labor-HHS-Education Act, NIH and CDC research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 15, 2020.
Original Filing: 301166764.xml
Lobbying Issues
Research Opportunities at the Department of Defense
FY21 Defense Appropriations Act, DoD research on vascular malformations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474, Department of Defense Appropriations Act 2020, research on vascular malformations
HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020, NIH research on HHT
HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Lobbying Issues
Research Opportunities at the Department of Defense, the National Institutes of Health, and the Centers for Disease Control and Prevention
FY21 Defense Appropriations Act, DoD research on vascular malformations
FY21 Labor-HHS-Education Act, NIH and CDC research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 15, 2020.
Original Filing: 301106340.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474, Department of Defense Appropriations Act 2020, research on vascular malformations
HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020, NIH research on HHT
HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474, Department of Defense Appropriations Act 2020, research on vascular malformations
HR 1158, Consolidated Appropriations Act, DoD research on vascular malformations
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020, NIH research on HHT
HR 1865, Further Consolidated Appropriations Act, NIH research on HHT
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069054.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474, Department of Defense Appropriations Act 2020
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474, Department of Defense Appropriations Act 2020
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474 Department of Defense Appropriations Act 2020
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2019
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 11, 2019.
Original Filing: 301044482.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968, Department of Defense Appropriations Act 2020
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968, Department of Defense Appropriations Act 2020
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2019
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on May 23, 2019.
Original Filing: 301041365.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR2470/S3159, FY20 Defense, Labor, HHS Education Appropriations Act
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control
HR2470/S3159, FY20 Defense, Labor, HHS Education Appropriations Act
Defense Medical Research, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2018
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 18, 2019.
Original Filing: 301007734.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, defense medical research, NIH Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense, NIH and the Centers for Disease Control.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2018
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 18, 2018.
Original Filing: 300989115.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, defense medical research, NIH Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Defense
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, defense medical research, NIH Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2018
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 16, 2018.
Original Filing: 300965329.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 6157/S 3159, FY19 Defense Appropriations Act, defense medical research
No HR bill no/S 3158, FY19 Labor HHS Education Appropriations Act, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
HR 6157/S 3159, FY19 Defense Appropriations Act, defense medical research
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 6157/S 3159, FY19 Defense Appropriations Act, defense medical research
No HR bill no/S 3158, FY19 Labor HHS Education Appropriations Act, NIH funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2018
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 18, 2018.
Original Filing: 300947837.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 1625, Consolidated Appropriations Act FY19, defense medical research programs and CDC funding for bleeding disorders
FY19 Defense Appropriations, defense medical research, no bill numbers
FY19 Labor HHS Education Appropriations Act, NIH funding, no bill numbers
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
HR 3219/ HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 1625, Consolidated Appropriations Act FY19, defense medical research programs and CDC funding for bleeding disorders
FY19 Defense Appropriations, defense medical research, no bill numbers
FY19 Labor HHS Education Appropriations Act, NIH funding, no bill numbers
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 1625, Consolidated Appropriations Act FY19, defense medical research programs and CDC funding for bleeding disorders
FY19 Defense Appropriations, defense medical research, no bill numbers
FY19 Labor HHS Education Appropriations Act, NIH funding, no bill numbers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2017
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 22, 2018.
Original Filing: 300934299.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
HR 3219/ HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2017
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905510.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs
HR 1628, Better Care Reconciliation Act
HR 1628, American Health Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
HR 3219/ HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research
HR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs
HR 1628, Better Care Reconciliation Act
HR 1628, American Health Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2017
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 18, 2017.
Original Filing: 300886746.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
FY 2017, Defense Appropriations Act, defense health programs.
HR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance
HR 3219, FY 18 Defense Appropriations Act, defense medical research
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
FY17 Defense Appropriations Act
HR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance
HR 3219, FY 18 Defense Appropriations Act, defense medical research
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
FY 2017, Defense Appropriations Act, defense health programs.
HR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance
HR 3219, FY 18 Defense Appropriations Act, defense medical research
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
FY 2017, Defense Appropriations Act, defense health programs.
HR 1628, American Health Care Act, Medicaid and Essential Health Benefits
HR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance
HR 3219, FY 18 Defense Appropriations Act, defense medical research
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2017
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 13, 2017.
Original Filing: 300864840.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S3040/HR5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR5293/S3000, FY 2017, Defense Appropriations Act, defense health programs.
S2943, National Defense Authorization Act, funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
HR 1301, FY 2017 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S3040/HR5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR5293/S3000, FY 2017, Defense Appropriations Act, defense health programs.
S2943, National Defense Authorization Act, funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 1301, FY 2017, Defense Appropriations Act, defense health programs.
HR 1628, American Health Care Act, Medicaid and Essential Health Benefits
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2016
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 10, 2017.
Original Filing: 300844771.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S. 3040/ H.R. 5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S. 3040/ H.R. 5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2016
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on Jan. 6, 2017 to represent Cure HHT Foundation, effective Dec. 1, 2016.
Original Filing: 300843950.xml
Issue(s) they said they’d lobby about: Research opportunities at the Department of Defense & Centers for Disease Control; Labor HHS Appropriations Act, Defense Appropriations Act .
3rd Quarter, 2016
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 17, 2016.
Original Filing: 300829240.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S. 3040/ H.R. 5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
H.R. 1849, HHT Diagnosis and Treatment Act
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S. 3040/ H.R. 5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
H.R. 1849, HHT Diagnosis and Treatment Act
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 19, 2016.
Original Filing: 300814386.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S. 3040/ no House Bill #, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
H.R. 1849, HHT Diagnosis and Treatment Act
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Budget/Appropriations Defense
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
S. 3040/ no House Bill #, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs
H.R. 1849, HHT Diagnosis and Treatment Act
S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 13, 2016.
Original Filing: 300790814.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
FY 2017 Defense Appropriations Act, defense health programs
H.R. 1849, HHT Diagnosis and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2017 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
FY 2017, Defense Appropriations Act, defense health programs
HR 1849, HHT Diagnosis and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders
FY 2017, Defense Appropriations Act, defense health programs
HR 1849, HHT Diagnosis and Treatment Act
HR 2029, Consolidated Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Jan. 14, 2016.
Original Filing: 300772199.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3020/S 1695, FY 2016, Labor-HHS Appropriations Act, blood and bleeding disorders
HR 2685/S 1558, FY 2016 Defense Appropriations Act, defense health programs
HR 1847, HHT Diagnosis and Treatment Act
HR 2029, Consolidated Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2685/S 1695, FY 2016 Defense Appropriations Act, defense health programs
HR 2029, Consolidated Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 15, 2015.
Original Filing: 300753764.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3020/S 1695, FY 2016, Labor-HHS Appropriations Act, blood and bleeding disorders
HR 2685/S 1558, FY 2016 Defense Appropriations Act, defense health programs
HR 1847, HHT Diagnosis and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2685/S 1695, FY 2016 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on Oct. 15, 2015.
Original Filing: 300753768.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3020/S 1695, FY 2016, Labor-HHS Appropriations Act, blood and bleeding disorders
HR 2685/S 1558, FY 2016 Defense Appropriations Act, defense health programs
HR 1847, HHT Diagnosis and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2685/S 1695, FY 2016 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on July 15, 2015.
Original Filing: 300734715.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
HR 3020/S 1695, FY 2016, Labor-HHS Appropriations Act, blood and bleeding disorders
HR 2685/S 1558, FY 2016 Defense Appropriations Act, defense health programs
HR 1847, HHT Diagnosis and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 2685/S 1695, FY 2016 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $10,000. The report was filed on April 15, 2015.
Original Filing: 300716132.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
No bill #, FY 2016, Labor-HHS Appropriations Act, blood and bleeding disorders
No bill #, FY 2016 Defense Appropriations Act, defense health programs
No bill #, HHT Diagnosis and Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
No bill #, FY 2016 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation , earning $5,000. The report was filed on Jan. 15, 2015.
Original Filing: 300696085.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
No bill #, FY 2015 Labor-HHS Appropriations Act, blood and bleeding disorders
HR 4870, FY 2015 Defense Appropriations Act, defense health programs
HR 83, Consolidated Appropriations Act FY 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Research opportunities at the Department of Defense
HR 4870, FY 2015 Defense Appropriations Act, defense health programs
HR 83, Consolidated Appropriations Act FY 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation . The report was filed on Oct. 16, 2014.
Original Filing: 300677795.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
No bill #, FY 2015 Labor-HHS Appropriations Act, blood and bleeding disorders
HR 4870, FY 2015 Defense Appropriations Act, defense health programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research opportunities at the Department of Defense.
HR 4870, FY 2015 Defense Appropriations Act, defense health programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation . The report was filed on July 16, 2014.
Original Filing: 300657863.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
No HR #, No S#, FY 2015 Labor-HHS Appropriations Act, Centers for Disease Control funding for HHT.
HR 4870, No S. #, FY 2015 Defense Appropriations Act, research into "vascular malformations."
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
Research opportunities at the Department of Defense
HR 4870, No S. #, FY 2015 Defense Appropriations Act, research into "vascular malformations."
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
1st Quarter, 2014
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation . The report was filed on April 11, 2014.
Original Filing: 300634342.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2015 Labor-HHS Appropriations Act
FY 2015 Defense Appropriations Act
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) U.S. House of Representatives U.S. Senate
Lobbying Issues
Research opportunities at the Department of Defense.
FY 2015 Defense Appropriations Act
Agencies Lobbied
Defense - Dept of (DOD) U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia Foundation . The report was filed on Jan. 10, 2014.
Original Filing: 300612350.xml
Lobbying Issues
Research opportunities at the Department of Defense and the Centers for Disease Control.
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) Defense - Dept of (DOD)
Type of Issue
Budget/Appropriations Defense
4th Quarter, 2013
Cavarocchi, Ruscio, Dennis & Associates, LLC filed a lobbying registration on Jan. 7, 2014 to represent Hereditary Hemorrhagic Telangiectasia Foundation, effective Nov. 19, 2013.
Original Filing: 300612008.xml
Issue(s) they said they’d lobby about: Research opportunities at the Department of Defense and the Centers for Disease Control .
4th Quarter, 2011
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. terminated an engagement in which they represented Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc. on Jan. 18, 2012.
Original Filing: 300440886.xml
Lobbying Issues
S. 1599, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research
HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2011
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc. , earning $20,000. The report was filed on Oct. 17, 2011.
Original Filing: 300415309.xml
Lobbying Issues
S. 1599, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research
HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2011
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc. , earning $20,000. The report was filed on July 12, 2011.
Original Filing: 300387852.xml
Lobbying Issues
No Bill #, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research
Continuing Resolutions, FY 2011
HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc. , earning $20,000. The report was filed on April 14, 2011.
Original Filing: 300363901.xml
Lobbying Issues
No Bill #, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research
Continuing Resolutions, FY 2011
No Bill#, HHT Research and Treatment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC)
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc. , earning $20,000. The report was filed on Jan. 19, 2011.
Original Filing: 300342976.xml
Lobbying Issues
H.R.-No Bill #/S. 3686, Labor/HHS/Education Appropritions Bill, FY 2011, HHT research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2010
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc. , earning $10,000. The report was filed on Oct. 15, 2010.
Original Filing: 300313638.xml
Lobbying Issues
H.R.-No Bill #/S. 3686, Labor/HHS/Education Appropritions Bill, FY 2011, HHT research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on Oct. 12, 2010 to represent Hereditary Hemorrhagic Telangiectasia (HHT) Foundation International, Inc., effective Sept. 1, 2010.
Original Filing: 300311152.xml
Issue(s) they said they’d lobby about: Funding for HHT surveillance at CDC
Funding for HHT Clinical Resarch Consortium within NIH
Health research funding within DOD, VA .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate